![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[Article Abstract]](/e/graphics/abstractborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Issue contents]](/e/graphics/issuecontentsborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](hg6144contents.gif)
Acta Cryst. (2005). E61, o733-o735 [ doi:10.1107/S1600536805005209 ]
Methyl 2-methyl-5-oxo-4-(2-thienyl)-1,5,7,8,9,10-hexahydro-4H-pyrido[2',3':3,4]pyrrolo[1,2-a][1,3]diazepine-3-carboxylate
V. Vrábel, J. Kozísek, S. Marchalín and I. Svoboda
Online 26 February 2005
Copyright © International Union of Crystallography
IUCr Webmaster